BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35438422)

  • 1. Clinical profile of melanocytic lesions of the ocular surface in a Hispanic population.
    Garza-Garza LA; Ramos-Davila EM; Ruiz-Lozano RE; Gutierrez-Juarez K; Hernandez-Camarena JC
    Int Ophthalmol; 2022 Sep; 42(9):2765-2772. PubMed ID: 35438422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
    Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
    Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigmented conjunctival and scleral lesions.
    Liesegang TJ
    Mayo Clin Proc; 1994 Feb; 69(2):151-61. PubMed ID: 8309267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pigmented conjunctival lesions.
    Oellers P; Karp CL
    Ocul Surf; 2012 Oct; 10(4):251-63. PubMed ID: 23084146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of melanocytic conjunctival tumors.
    Halas JM; Svetlosakova Z; Babal P
    Bratisl Lek Listy; 2013; 114(8):446-50. PubMed ID: 23944618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding of conjunctival melanocytic pigmented lesions within pterygium.
    Perra MT; Colombari R; Maxia C; Zucca I; Piras F; Corbu A; Bravo S; Scarpa A; Sirigu P
    Histopathology; 2006 Mar; 48(4):387-93. PubMed ID: 16487360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current appraisal of conjunctival melanocytic tumors: classification and treatment.
    Harooni H; Schoenfield LR; Singh AD
    Future Oncol; 2011 Mar; 7(3):435-46. PubMed ID: 21417906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Focus on clinical and pathological management of conjunctival melanocytic tumors].
    Lassalle S; Caujolle JP; Leger F; Maschi C; Gastaud L; Nahon-Esteve S; Thariat J; Baillif S; Hofman P
    Ann Pathol; 2018 Jun; 38(3):153-163. PubMed ID: 29803361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjunctival melanocytic lesions in children.
    McDonnell JM; Carpenter JD; Jacobs P; Wan WL; Gilmore JE
    Ophthalmology; 1989 Jul; 96(7):986-93. PubMed ID: 2771364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ultrastructure of conjunctival melanocytic tumors.
    Jakobiec FA
    Trans Am Ophthalmol Soc; 1984; 82():599-752. PubMed ID: 6398936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota.
    Dalvin LA; Salomão DR; Patel SV
    Br J Ophthalmol; 2018 Dec; 102(12):1728-1734. PubMed ID: 29511061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study.
    Seregard S; af Trampe E; Månsson-Brahme E; Kock E; Bergenmar M; Ringborg U
    Ophthalmology; 1995 Oct; 102(10):1524-9. PubMed ID: 9097801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
    Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
    Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME Expression in Junctional Melanocytic Proliferations of the Conjunctiva: A Potential Biomarker for Primary Acquired Melanosis/Conjunctival Melanocytic Intraepithelial Lesions.
    Huang YY; Hrycaj SM; Chan MP; Stagner AM; Patel RM; Bresler SC
    Am J Dermatopathol; 2022 Oct; 44(10):734-740. PubMed ID: 35475786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival pigmented lesion: Clinicopathological analysis of 85 cases in Korean population.
    Lee YJ; Lee C; Kim MK; Khwarg SI; Oh JY
    Sci Rep; 2019 Dec; 9(1):18204. PubMed ID: 31796811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.